The impact of amino acid variability on alloreactivity defines a functional distance predictive of permissive HLA-DPB1 mismatches in hematopoietic stem cell transplantation.
暂无分享,去创建一个
Martin Maiers | Luigi Naldini | Katharina Fleischhauer | Elisabetta Zino | L. Naldini | M. Maiers | F. Ciceri | F. Sizzano | K. Fleischhauer | A. Mulder | L. Vago | Fabio Ciceri | Luca Vago | Arend Mulder | Pietro Crivello | Laura Zito | Federico Sizzano | Cristina Toffalori | P. Crivello | C. Toffalori | E. Zino | L. Zito
[1] Harriet Noreen,et al. High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation. , 2007, Blood.
[2] M. Aljurf,et al. Identification of a permissible HLA mismatch in hematopoietic stem cell transplantation. , 2014, Blood.
[3] D. Blaise,et al. HLA Association with hematopoietic stem cell transplantation outcome: the number of mismatches at HLA-A, -B, -C, -DRB1, or -DQB1 is strongly associated with overall survival. , 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[4] M. Amicosante,et al. Detailed analysis of the effects of Glu/Lys beta69 human leukocyte antigen-DP polymorphism on peptide-binding specificity. , 2003, Tissue antigens.
[5] J. Falkenburg,et al. Patient HLA-DP-specific CD4+ T cells from HLA-DPB1-mismatched donor lymphocyte infusion can induce graft-versus-leukemia reactivity in the presence or absence of graft-versus-host disease. , 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[6] Katharina Fleischhauer,et al. Frequency and targeted detection of HLA-DPB1 T cell epitope disparities relevant in unrelated hematopoietic stem cell transplantation. , 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[7] E Lanino,et al. Bone marrow transplantation from unrelated donors: the impact of mismatches with substitutions at position 116 of the human leukocyte antigen class I heavy chain. , 2001, Blood.
[8] Barbara Bruno,et al. Nonpermissive HLA-DPB1 disparity is a significant independent risk factor for mortality after unrelated hematopoietic stem cell transplantation. , 2009, Blood.
[9] D. Miklos,et al. Risk-associations between HLA-DPB1 T cell epitope matching and outcome of unrelated hematopoietic cell transplantation are independent from HLA-DPA1 , 2014, Bone Marrow Transplantation.
[10] M. Amicosante,et al. Functional analysis of HLA-DP polymorphism: a crucial role for DPbeta residues 9, 11, 35, 55, 56, 69 and 84-87 in T cell allorecognition and peptide binding. , 2003, International immunology.
[11] P. Greenberg,et al. Use of CD137 to study the full repertoire of CD8+ T cells without the need to know epitope specificities , 2008, Cytometry. Part A : the journal of the International Society for Analytical Cytology.
[12] A. Gratwohl,et al. Impact of HLA-DPB1 haplotypes on outcome of 10/10 matched unrelated hematopoietic stem cell donor transplants depends on MHC-linked microsatellite polymorphisms. , 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[13] M. Betjes,et al. Activation‐induced CD137 is a fast assay for identification and multi‐parameter flow cytometric analysis of alloreactive T cells , 2013, Clinical and experimental immunology.
[14] J. Madrigal,et al. Translating the HLA-DPB1 T-cell epitope-matching algorithm into clinical practice , 2013, Bone Marrow Transplantation.
[15] L. Naldini,et al. Coordinate dual-gene transgenesis by lentiviral vectors carrying synthetic bidirectional promoters , 2005, Nature Biotechnology.
[16] Tao Wang,et al. Evaluation of HLA matching in unrelated hematopoietic stem cell transplantation for nonmalignant disorders. , 2012, Blood.
[17] C. Nombela,et al. HLA-DPbeta residue 69 plays a crucial role in allorecognition. , 1998, Tissue Antigens.
[18] Douglas G. Mack,et al. Crystal structure of HLA-DP2 and implications for chronic beryllium disease , 2010, Proceedings of the National Academy of Sciences.
[19] C. Bordignon,et al. Peripheral blood stem cell allograft rejection mediated by CD4+ T lymphocytes recognizing a single mismatch at HLA-DPβ1*0901 , 2001 .
[20] A. Bacigalupo. A closer look at permissive HLA mismatch. , 2013, Blood.
[21] Xu Liu,et al. Development and Validation of a Gamma Interferon ELISPOT Assay for Quantitation of Cellular Immune Responses to Varicella-Zoster Virus , 2001, Clinical Diagnostic Laboratory Immunology.
[22] J. Kuball,et al. Refinement of the definition of permissible HLA-DPB1 mismatches with predicted indirectly recognizable HLA-DPB1 epitopes. , 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[23] J. Madrigal,et al. The impact of HLA genotyping on survival following unrelated donor haematopoietic stem cell transplantation , 2010, British journal of haematology.
[24] F. Sizzano,et al. Significantly higher frequencies of alloreactive CD4+ T cells responding to nonpermissive than to permissive HLA-DPB1 T-cell epitope disparities. , 2010, Blood.
[25] M. Tilanus,et al. Effects of transmembrane region variability on cell surface expression and allorecognition of HLA-DP3. , 2013, Human immunology.
[26] Anajane G. Smith,et al. The biological significance of HLA‐DP gene variation in haematopoietic cell transplantation , 2001, British journal of haematology.
[27] H. Inoko,et al. Cloned primed lymphocyte test cells recognize the fourth, fifth, and sixth hypervariable regions at amino acid positions 65-87 of the DPB1 molecule. , 1995, Human immunology.
[28] C. Bordignon,et al. Peripheral blood stem cell allograft rejection mediated by CD4(+) T lymphocytes recognizing a single mismatch at HLA-DP beta 1*0901. , 2001, Blood.
[29] Maria Pia Sormani,et al. A T-cell epitope encoded by a subset of HLA-DPB1 alleles determines nonpermissive mismatches for hematologic stem cell transplantation. , 2003, Blood.
[30] Medhat Askar,et al. Nonpermissive HLA-DPB1 mismatch increases mortality after myeloablative unrelated allogeneic hematopoietic cell transplantation. , 2014, Blood.
[31] M. Schell,et al. Race/ethnicity affects the probability of finding an HLA-A, -B, -C and -DRB1 allele-matched unrelated donor and likelihood of subsequent transplant utilization , 2013, Bone Marrow Transplantation.
[32] J. Wagner,et al. Effect of graft source on unrelated donor haemopoietic stem-cell transplantation in adults with acute leukaemia: a retrospective analysis. , 2010, The Lancet. Oncology.
[33] Loren Gragert,et al. HLA match likelihoods for hematopoietic stem-cell grafts in the U.S. registry. , 2014, The New England journal of medicine.
[34] E. Petersdorf. Optimal HLA matching in hematopoietic cell transplantation. , 2008, Current opinion in immunology.
[35] J. Pidala,et al. Amino acid substitution at peptide-binding pockets of HLA class I molecules increases risk of severe acute GVHD and mortality. , 2013, Blood.
[36] C. Nombela,et al. HLA-DPp residue 69 plays a crucial role in allorecognition , 1998 .
[37] L. Zhao,et al. Effect of MHC and non-MHC donor/recipient genetic disparity on the outcome of allogeneic HCT. , 2012, Blood.
[38] Lili Wang,et al. Formalization of the MESF unit of fluorescence intensity , 2004, Cytometry. Part B, Clinical cytometry.
[39] Brent R Logan,et al. A perspective on the selection of unrelated donors and cord blood units for transplantation. , 2012, Blood.
[40] H. Bickeböller,et al. Impact of HLA‐DPB1 allelic and single amino acid mismatches on HSCT , 2008, British journal of haematology.
[41] C. Carcassi,et al. Graft rejection after unrelated donor hematopoietic stem cell transplantation for thalassemia is associated with nonpermissive HLA-DPB1 disparity in host-versus-graft direction. , 2006, Blood.
[42] Effie W Petersdorf,et al. Effect of T-cell-epitope matching at HLA-DPB1 in recipients of unrelated-donor haemopoietic-cell transplantation: a retrospective study. , 2012, The Lancet. Oncology.